Skip to main content
C

ConjuChem Biotechnologies Inc. — Investor Relations & Filings

Ticker · CJHMF TSX Manufacturing
Filings indexed 0 across all filing types
Latest filing no filings yet
Country CA Canada
Listing TSX CJHMF

About ConjuChem Biotechnologies Inc.

https://www.conjuchem.com/

ConjuChem Biotechnologies Inc. is a biotechnology company specializing in the discovery and development of novel, next-generation medicines utilizing therapeutic peptides. The company employs proprietary bioconjugation platforms, known as Drug Affinity Complex (DAC™) and Preformed Conjugate-Drug Affinity Complex (PC-DAC™). These technologies are designed to extend the duration of activity and improve the safety profiles of peptide-based drugs. By applying DAC™ and PC-DAC™ to therapeutic peptides, ConjuChem creates long-acting compounds intended for the treatment of various medical conditions, such as Type 2 diabetes.

Recent filings

No filings indexed yet

We are still gathering filings for ConjuChem Biotechnologies Inc.. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.